STERIS plc (NYSE:STE) Shares Bought by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP raised its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 5.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 909,521 shares of the medical equipment provider's stock after acquiring an additional 47,637 shares during the period. Dimensional Fund Advisors LP owned approximately 0.92% of STERIS worth $186,961,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Geode Capital Management LLC raised its stake in shares of STERIS by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 2,359,748 shares of the medical equipment provider's stock valued at $483,775,000 after buying an additional 56,123 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of STERIS by 15.9% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,261,927 shares of the medical equipment provider's stock valued at $257,585,000 after purchasing an additional 172,795 shares during the period. Franklin Resources Inc. boosted its holdings in STERIS by 45.1% during the fourth quarter. Franklin Resources Inc. now owns 1,216,821 shares of the medical equipment provider's stock worth $250,130,000 after buying an additional 378,252 shares in the last quarter. Norges Bank acquired a new stake in STERIS during the fourth quarter valued at $238,836,000. Finally, Bessemer Group Inc. increased its holdings in STERIS by 0.5% in the fourth quarter. Bessemer Group Inc. now owns 1,141,125 shares of the medical equipment provider's stock valued at $234,569,000 after buying an additional 5,434 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

STERIS Price Performance

Shares of NYSE:STE traded down $0.72 during midday trading on Tuesday, hitting $224.54. The company's stock had a trading volume of 133,464 shares, compared to its average volume of 524,934. STERIS plc has a 12-month low of $200.98 and a 12-month high of $248.24. The company has a market cap of $22.06 billion, a P/E ratio of 47.75 and a beta of 0.87. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The business's 50 day simple moving average is $222.97 and its 200 day simple moving average is $218.84.

STERIS (NYSE:STE - Get Free Report) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, analysts forecast that STERIS plc will post 9.08 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. JMP Securities reissued a "market outperform" rating and set a $265.00 target price on shares of STERIS in a research note on Thursday, April 10th. Piper Sandler raised their price objective on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Stephens reaffirmed an "overweight" rating and set a $240.00 target price on shares of STERIS in a research note on Thursday, February 6th. Finally, Needham & Company LLC reissued a "hold" rating on shares of STERIS in a report on Monday, April 7th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.